Literature DB >> 583261

Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases.

K Bech, S Nistrup Madsen.   

Abstract

The occurrence of serum immunoglobulins with capacity to stimulate thyroid adenylate cyclase (TSAb) was studied in seventy-two healthy volunteers and 120 unselected patients with various thyroid diseases. A high frequency of TSAb (82.5%, P less than 0.00006) was found in Graves' disease, while TSAb was present only in 13--20% of serum from patients with nontoxic nodular goitre, nontoxic diffuse goitre, toxic adenoma, toxic nodular goitre and myxoedema. These patients had low level of TSAb compared to patients with Graves' disease. In patients with Graves' disease there was no correlation between the level of TSAb and hormonal status except serum triiodothyronine (rs = 0.29, P less than 0.05), and no relation with eye involvement or presence of microsomal thyroid antibodies was found. The results indicate that the human thyroid adenylate cyclase assay system with 1 hour incubation periods is a sensitive method for detection of immunoglobulins with TSH-like capacity to stimulate the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583261     DOI: 10.1111/j.1365-2265.1979.tb03045.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Thyroid function in patients with Pendred's syndrome.

Authors:  J Friis; T Johnsen; U Feldt-Rasmussen; K Bech; T Friis
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

2.  Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.

Authors:  J Ginsberg; C von Westarp
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

3.  Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.

Authors:  J R Baker; Y G Lukes; K D Burman
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

4.  Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.

Authors:  J Charreire; G Karsenty; P Bouchard; G Schaison
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  The role of interferon-gamma in lymphocytic thyroiditis: its functional and pathological effect on human thyrocytes in culture.

Authors:  A W Kung; L Ma; K S Lau
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

6.  Thyroid stimulating antibodies in rheumatoid arthritis: an in vitro phenomenon.

Authors:  C Kirkegaard; K Bech; H Bliddal; B Danneskiold-Samsoe; U Feldt-Rasmussen
Journal:  J Endocrinol Invest       Date:  1987-10       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.